Recursion Pharmaceuticals (NASDAQ:RXRX) CEO Sells 22,408 Shares
MarketBeat
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) CEO Najat Khan sold 22,408 shares of Recursion Pharmaceuticals stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $3.52, for a total value of $78,876.16. Following the completion of the transaction, the chief executive officer directly owned 2,072,890 shares in the company, valued at $7,296,572.80. This represents a 1.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:RXRX